Skip to main content

Table 6 The mean lifetime attributed cancer mortality risks due to whole lung low dose radiotherapy (with a prescribed dose equal to 1 Gy) in 3D-CRT AP–PA technique for adult male and female patients at different ages

From: Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia

 

Age at exposure time (years)

20

30

40

50

60

70

80

Male

Stomach

0.122

0.093

0.087

0.075

0.064

0.046

0.023

Liver

0.131

0.091

0.091

0.080

0.068

0.046

0.023

Lung

1.767

1.819

1.252

1.217

1.088

0.831

0.491

Other

0.281

0.197

0.185

0.162

0.122

0.076

0.036

All solids

2.301

1.633

1.615

1.534

1.342

0.998

0.573

Female

Stomach

0.168

0.122

0.116

0.110

0.093

0.075

0.046

Liver

0.068

0.051

0.046

0.046

0.040

0.029

0.017

Lung

3.569

2.492

2.480

2.387

2.141

1.638

0.948

Breast

1.232

0.744

0.427

0.232

0.110

0.061

0.024

Other

0.309

0.216

0.204

0.181

0.145

0.099

0.050

All solids

5.209

3.597

3.334

3.041

2.594

1.942

1.114

  1. Risk values are presented as incidence probability per 100 individuals
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us